Park Medi World Board of Directors

Get the latest insights into the leadership at Park Medi World. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Dr. Ajit Gupta Chairman & Wholetime Director
Dr. Ankit Gupta Managing Director
Dr. Sanjay Sharma WholeTime Director & CEO
Mr. Ravi Krishan Takkar Ind. Non-Executive Director
Mr. Munish Sibal Ind. Non-Executive Director
Dr. Kamlesh Kohli Ind. Non-Executive Director

Park Medi World Share price

PARKHOSPS

147.6

2.40 (-1.60%)
NSE
BSE
Last updated on 6 Jan, 2026 | 15:58 IST
alert_iconwatchlist_icon
BUYSELL
Today's High

150.49

Today's Low

146.46

52 Week Low

138.10

52 Week High

165.87

alert_iconThe current prices are delayed, login to your account for live prices

Park Medi World FAQs

The board at Park Medi World consists of experienced professionals, including Dr. Ajit Gupta , Dr. Ankit Gupta , and others, overseeing the company’s strategic and corporate governance.

Directors at Park Medi World are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Dr. Ajit Gupta is the current chairman at Park Medi World.

Executive directors at Park Medi World are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Park Medi World adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Park Medi World, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.